Minimization of chronic plasma viremia in rhesus macaques immunized with synthetic HIV-1 Tat peptides and infected with a chimeric simian/human immunodeficiency virus (SHIV33)

Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection

John W. Mellors · Annals of Internal Medicine · 1997 · 2.1K citations

Life Sciences, Immunology, Infectious Diseases +16

<i>HLA</i>and HIV-1: Heterozygote Advantage and<i>B*35</i>-<i>Cw*04</i>Disadvantage

Mary Carrington, George W. Nelson, Maureen P. Martin et al. · Science · 1999 · 1.2K citations

Life Sciences, Genetics, Immunology +17

Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

Persephone Borrow, Hanna Lewicki, Xiping Wei et al. · Nature Medicine · 1997 · 1.2K citations

Life Sciences, Immunology, Infectious Diseases +17

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

Rodney E. Phillips, Sarah Rowland‐Jones, Douglas F. Nixon et al. · Nature · 1991 · 1K citations

Life Sciences, Genetics, Immunology +14

Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

Barbara Ensoli, Giovanni Barillari, S. Zaki Salahuddin et al. · Nature · 1990 · 895 citations

Life Sciences, Infectious Diseases, Molecular Biology +9